Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | PAN domain-containing protein | 0.0637 | 0.7579 | 1 |
Echinococcus granulosus | laminin | 0.046 | 0 | 0.5 |
Onchocerca volvulus | 0.0693 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0693 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0693 | 1 | 1 |
Echinococcus multilocularis | Tolloid protein 1 | 0.046 | 0 | 0.5 |
Toxoplasma gondii | PAN domain-containing protein | 0.0637 | 0.7579 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0693 | 1 | 1 |
Onchocerca volvulus | 0.0549 | 0.3815 | 0.3815 | |
Echinococcus multilocularis | laminin | 0.046 | 0 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0693 | 1 | 1 |
Echinococcus granulosus | Tolloid protein 1 | 0.046 | 0 | 0.5 |
Echinococcus multilocularis | fibrillin 1 | 0.046 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.